Anti-HLA and anti-SARS-CoV-2 antibodies in kidney transplant recipients with COVID-19.
作者信息
Gandolfini Ilaria, Zanelli Paola, Palmisano Alessandra, Salvetti Daniel, Parmigiani Alice, Maltzman Jonathan S, Labate Claudia, Fiaccadori Enrico, Cravedi Paolo, Maggiore Umberto
机构信息
Dipartimento di Medicina e Chirurgia, UO Nefrologia, Azienda Ospedaliera-Universitaria Parma, Università di Parma, Parma, Italy.
Immunogenetica dei trapianti, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
出版信息
Transpl Int. 2021 Mar;34(3):596-599. doi: 10.1111/tri.13829. Epub 2021 Feb 26.
Abstract
摘要
相似文献
1
Anti-HLA and anti-SARS-CoV-2 antibodies in kidney transplant recipients with COVID-19.感染新型冠状病毒肺炎的肾移植受者体内的抗人白细胞抗原抗体和抗新型冠状病毒抗体
Transpl Int. 2021 Mar;34(3):596-599. doi: 10.1111/tri.13829. Epub 2021 Feb 26.
2
Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration.肾移植受者在首次接种新冠疫苗后很少出现早期抗体反应。
Transplantation. 2021 Jul 1;105(7):e72-e73. doi: 10.1097/TP.0000000000003764.
3
COVID-19 does not impact HLA antibody profile in a series of waitlisted renal transplant candidates.新型冠状病毒肺炎对一系列等待肾移植的候选者的人类白细胞抗原抗体谱无影响。
Hum Immunol. 2021 Aug;82(8):568-573. doi: 10.1016/j.humimm.2021.04.002. Epub 2021 Apr 17.
4
HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors.在一个地区性男性新冠康复者血浆捐献者群体中，HLA抗体率并未升高。
Mayo Clin Proc. 2021 Oct;96(10):2727-2728. doi: 10.1016/j.mayocp.2021.08.004. Epub 2021 Aug 20.
5
Seroprevalence of SARS-CoV-2 IgG antibodies in the current COVID-19 pandemic amongst co-workers at a UK renal transplant centre.英国一家肾移植中心工作人员在当前新冠疫情期间的新冠病毒2型免疫球蛋白G抗体血清流行率。
Transpl Int. 2021 Feb;34(2):382-383. doi: 10.1111/tri.13791.
6
Donor-Specific HLA Antibody IgG Subclasses Are Associated with Phenotypes of Antibody-Mediated Rejection in Sensitized Renal Allograft Recipients.供者特异性 HLA 抗体 IgG 亚类与致敏肾移植受者抗体介导排斥反应的表型相关。
J Am Soc Nephrol. 2016 Jan;27(1):6-8. doi: 10.1681/ASN.2015060608. Epub 2015 Aug 20.
7
Immunoinformatic based identification of cytotoxic T lymphocyte epitopes from the Indian isolate of SARS-CoV-2.基于免疫信息学的 SARS-CoV-2 印度分离株细胞毒性 T 淋巴细胞表位鉴定。
Sci Rep. 2021 Feb 25;11(1):4516. doi: 10.1038/s41598-021-83949-9.
8
COVID-19 Infection in Kidney Transplant Recipients in Italy: Management Issues in a Kidney Transplant Center.意大利肾移植受者中的新型冠状病毒肺炎感染：一家肾移植中心的管理问题
Exp Clin Transplant. 2021 Mar;19(3):284-286. doi: 10.6002/ect.2020.0151. Epub 2021 Jan 11.
9
Influence of HLA antigens of renal transplant recipients on graft survival.肾移植受者的HLA抗原对移植物存活的影响。
Transplant Proc. 1992 Dec;24(6):2461-2.
10
Renal transplantation during the SARS-CoV-2 pandemic in the UK: Experience from a large-volume center.在 SARS-CoV-2 大流行期间在英国进行肾移植：来自大容量中心的经验。
Clin Transplant. 2021 Jan;35(1):e14150. doi: 10.1111/ctr.14150. Epub 2020 Nov 23.
引用本文的文献
1
Impact of COVID-19 pandemic on transplant laboratories: How to mitigate?2019冠状病毒病大流行对移植实验室的影响：如何缓解？
Heliyon. 2024 Feb 15;10(4):e26419. doi: 10.1016/j.heliyon.2024.e26419. eCollection 2024 Feb 29.
2
HLA Sensitization in the Era of COVID-19: Single-Center Experience.COVID-19 时代的 HLA 致敏：单中心经验。
Transplant Proc. 2022 Dec;54(10):2658-2662. doi: 10.1016/j.transproceed.2022.10.024. Epub 2022 Oct 7.
3
Immune responses to SARS-CoV-2 in dialysis and kidney transplantation.透析和肾移植中对严重急性呼吸综合征冠状病毒2的免疫反应。
Clin Kidney J. 2022 Jul 27;15(10):1816-1828. doi: 10.1093/ckj/sfac174. eCollection 2022 Oct.
4
Screening for antibodies to HLA class I in apheresis donors following Covid-19 or SARS-CoV-2 vaccination.在接受过新冠病毒或 SARS-CoV-2 疫苗接种的献血者中筛查 HLA Ⅰ类抗体。
Transfus Apher Sci. 2022 Oct;61(5):103567. doi: 10.1016/j.transci.2022.103567. Epub 2022 Aug 30.
5
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response.SARS-CoV-2 感染透析和肾移植患者：免疫和血清学反应。
J Nephrol. 2022 Apr;35(3):745-759. doi: 10.1007/s40620-021-01214-8. Epub 2022 Jan 24.
6
SARS Cov-2 vaccination induces de novo donor-specific HLA antibodies in a renal transplant patient on waiting list: A case report.SARS-CoV-2 疫苗接种可诱导等待肾移植的患者产生新的 HLA 特异性供体抗体：病例报告。
HLA. 2022 Jan;99(1):25-30. doi: 10.1111/tan.14492. Epub 2021 Nov 28.
本文引用的文献
1
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration.COVID-19 相关死亡率在肾移植和透析患者：ERACODA 合作的结果。
Nephrol Dial Transplant. 2020 Nov 1;35(11):1973-1983. doi: 10.1093/ndt/gfaa261.
2
Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients.自身免疫性肝炎中的2019冠状病毒病：来自免疫抑制患者的教训
Hepatol Commun. 2020 Jul 8;4(9):1257-1262. doi: 10.1002/hep4.1557. eCollection 2020 Sep.
3
Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.COVID-19 感染肾移植受者体内存在有效的体液免疫活性证据。
Am J Transplant. 2020 Nov;20(11):3149-3161. doi: 10.1111/ajt.16261. Epub 2020 Oct 2.
4
COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium.COVID-19 与肾移植：TANGO 国际移植联合会的研究结果。
Am J Transplant. 2020 Nov;20(11):3140-3148. doi: 10.1111/ajt.16185. Epub 2020 Aug 4.
5
COVID-19-related Mortality During the First 60 Days After Kidney Transplantation.肾移植后前60天内与COVID-19相关的死亡率
Eur Urol. 2020 Oct;78(4):641-643. doi: 10.1016/j.eururo.2020.06.036. Epub 2020 Jun 19.
6
Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study.在肾移植中免疫细胞功能检测和供体特异性 HLA 抗体的趋势：一项 3 年的前瞻性研究。
Am J Transplant. 2013 Dec;13(12):3215-22. doi: 10.1111/ajt.12503. Epub 2013 Oct 30.
Zotero 插件